CRISPR Can Analyze Why T Cells Remain Inactive Against Cancer and Enable Their Activation

The immune system is activated against cancer by immunotherapies, which offer results revolutionizing cancer treatment. Recently, besides immune checkpoints being targeted by drug-based immunotherapies, another goal is to turn patients' own immune cells into cancer fighters . One of the most important challenges in this field is that the complete genetic structure of immune cells and their associated pathways have not been completely clarified. In November 2018, Cell published a study developing a CRISPR-based system enabling detailed, rapid genetic analysis of each primary T cell taken from a patient. This development may pave the way for more effective, personalized immunotherapies.
Researchers named this CRISPR-developed technique SLICE . With SLICE, T cells were tested, yielding the following results:
- Cancer immunotherapies are effective only in certain cancer types. Using SLICE, researchers discovered genes enabling T-cell proliferation. This may allow more patients to benefit from cancer immunotherapy.
- Previously undiscovered using earlier techniques, genes enabling T-cell proliferation were identified. Researchers modified these genes in human T cells using CRISPR. In cell culture models, the modified T cells showed increased cancer-killing properties.
- Genes enabling immune suppression in the tumor microenvironment were also identified. When these genes were inhibited (suppressed), T cells actively attacked tumors in the tumor microenvironment.
So What Does This Study Mean for Us?
- An important technique has been developed to increase cancer immunotherapy's effectiveness. It may enable personalized and more effective immunotherapy medicines.
- One of the main reasons cancer immunotherapy often fails is the tumor microenvironment. The tumor microenvironment, suppresses immune T cells. This technique may enable treatment strategies allowing T cells to overcome that suppression.
- One limitation of T-cell immunotherapies was the incomplete knowledge of T-cell genetics. This technique allows every T cell from each patient to be analyzed quickly and easily.
- We are beginning to see CRISPR's impact on cancer research. Modern medicine continues to develop effective cancer treatment strategies using genetics and many other scientific fields.
Sources
Genome-wide CRISPR Screens in Primary Human T Cells Reveal Key Regulators of Immune Function.
Cell, 15 November 2018
Was this article helpful?
Your feedback helps us improve our content.





Reader comments
Share your comment
Your name and comment are published only after administrator approval. Your email address is never shown to visitors.
Be the first to comment.